Literature DB >> 37093

Abrupt withdrawal of beta-blocking agents in patients with arterial hypertension. Effect on blood pressure, heart rate and plasma catecholamines and prolactin.

O Lederballe Pedersen, E Mikkelsen, J Lanng Nielsen, N J Christensen.   

Abstract

Chronic treatment with beta-blockers was interrupted abruptly in six patients with arterial hypertension. Three patients, who had experienced symptoms during a previous withdrawal, again complained of transient palpitations, tremor, sweating, headache and general malaise. A significant increase in standing blood pressure (BP) and heart rate (HR) was noted after 24 h. The standing HR reached a maximum after 48 h and had decreased significantly on the 7th day (p less than 0.005). There was a strong tendency to greater increase in standing BP and HR in the patients who experienced symptoms than in those who did not. Plasma concentrations of noradrenaline, adrenaline and prolactin did not change significantly. Thus, beta-blocker withdrawal symptoms are reproducible and are indicative of a transient sympathetic hyperresponse. The increased activity is not likely to be caused by increased production of circulating catecholamines, but rather by increased sensitivity of the beta-receptor.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 37093     DOI: 10.1007/bf00563108

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  Homologous radioimmunoassay for human prolactin.

Authors:  A M Reuter; F Kennes; Y Gevaert; P Franchimont
Journal:  Int J Nucl Med Biol       Date:  1976-01

2.  Plasma noradrenaline and adrenaline in patients with thyrotoxicosis and myxoedema.

Authors:  N J Christensen
Journal:  Clin Sci Mol Med       Date:  1973-08

3.  Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy.

Authors:  R R Miller; H G Olson; E A Amsterdam; D T Mason
Journal:  N Engl J Med       Date:  1975-08-28       Impact factor: 91.245

4.  Comparison of metoprolol as hydrochlorothiazide and antihypertensive agents.

Authors:  O L Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1976       Impact factor: 2.953

5.  Decrease in serum-prolactin after propranolol in schizophrenia.

Authors:  T Hanssen; T Heyden; I Sundberg; L Wetterberg; P Eneroth
Journal:  Lancet       Date:  1978-01-14       Impact factor: 79.321

6.  Propranolol-induced increments in total and free serum thyroxine in patients with essential hypertension.

Authors:  B O Kristensen; J Weeke
Journal:  Clin Pharmacol Ther       Date:  1977-12       Impact factor: 6.875

7.  Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects.

Authors:  H Boudoulas; R P Lewis; R E Kates; G Dalamangas
Journal:  Ann Intern Med       Date:  1977-10       Impact factor: 25.391

8.  Propranolol withdrawal and thyroid hormones in patients with essential hypertension.

Authors:  B O Kristensen; E Steiness; J Weeke
Journal:  Clin Pharmacol Ther       Date:  1978-06       Impact factor: 6.875

9.  Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline.

Authors:  J L Reid; L M Wing; H J Dargie; C A Hamilton; D S Davies; C T Dollery
Journal:  Lancet       Date:  1977-06-04       Impact factor: 79.321

10.  Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension. Identification of abnormal central dopamine control.

Authors:  K O Stumpe; R Kolloch; M Higuchi; F Krück; H Vetter
Journal:  Lancet       Date:  1977-07-30       Impact factor: 79.321

View more
  13 in total

1.  Preoperative depression symptom severity and its impact on adherence to preoperative beta-blocker therapy.

Authors:  Robert B Schonberger; Jessica Feinleib; Natalie Holt; Feng Dai; Cynthia Brandt; Matthew M Burg
Journal:  J Cardiothorac Vasc Anesth       Date:  2014-09-26       Impact factor: 2.628

Review 2.  The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.

Authors:  B N Prichard; R J Walden
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

3.  Dissociation between duration of plasma catecholamine and blood pressure responses to beta-adrenergic blockade in normotensive subjects during physical exercise.

Authors:  G Planz; R Planz
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

4.  Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.

Authors:  R D Aarons; A S Nies; J Gal; L R Hegstrand; P B Molinoff
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

5.  Communicate with cancer patients: 2. Handling uncertainty, collusion, and denial.

Authors:  P Maguire; A Faulkner
Journal:  BMJ       Date:  1988-10-15

Review 6.  Drug deprescription-withdrawal risk, prevention, and treatment.

Authors:  Madison K Bangert; Gabriel M Aisenberg
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-12-20

7.  Abrupt withdrawal of pindolol or metoprolol after chronic therapy.

Authors:  E Szécsi; S Kohlschütter; W Schiess; E Lang
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 8.  Clinical consequences of abrupt drug withdrawal.

Authors:  C F George; D Robertson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

9.  β-blocker withdrawal among patients presenting for surgery from home.

Authors:  Robert B Schonberger; Carrie L Lukens; O Dicle Turkoglu; Jessica L Feinleib; Kenneth L Haspel; Matthew M Burg
Journal:  J Cardiothorac Vasc Anesth       Date:  2012-03-13       Impact factor: 2.628

10.  Withdrawal phenomena after atenolol and bopindolol: haemodynamic responses in healthy volunteers.

Authors:  R J Walden; B Tomlinson; B Graham; J B Liu; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.